Needle phobia is often treated like a minor inconvenience. A bit of a squeamish reaction to a routine blood test, or a slight shudder when getting a vaccine.
The data tells a completely different story.
New research from Numan shows that a fear of needles has contributed to an estimated 19.5 million missed NHS appointments across Britain. That's a quiet crisis that's cost our health service approximately £682 million.1
And the cost isn’t only financial. It’s locking millions of people out of treatments that could change their lives.
The silent barrier to obesity care
Right now, the most known weight loss treatments on the market are weekly injections. But for a huge portion of the population, a needle is an absolute dealbreaker.
Our survey of 2,000 UK adults found that 28% of Brits have delayed or avoided a medical appointment simply because it involved a needle.1 When you look specifically at people who are overweight or have obesity and struggle with needle anxiety, that number skyrockets to 58%.1
This fear is severely limiting the uptake of modern obesity care. Nearly one in five people who are actively interested in medical weight loss support say that a fear of injections is the primary barrier keeping them from starting.
A major shift in access
That’s starting to change. Oral weight loss pills mean evidence-based obesity care no longer comes attached to a needle.
The demand for a simpler option is clear:
53% of people considering weight loss medication say they’d take a daily pill. Only 24% would go for a weekly injection.1
88% of people currently using a weight loss injection would consider switching to a pill.1
Dr Tsolmon Tsogbayar: “Needle aversion is something we see regularly in clinical practice. There are many people who have wanted support with their weight for years but have struggled with the idea of injectable treatment, in some cases avoiding healthcare settings involving needles altogether.”
The danger of the shortcut
Whenever an effective treatment gets easier to take, a new risk shows up: unsafe, unregulated access.
Our data flagged a worrying trend. If affordability or NHS waiting lists get in the way, nearly 4 in 10 people say they’d consider buying weight loss pills from unregulated, illegal sources. Worryingly, 11% said their first stop would be social media, beauticians, or personal trainers.
These are powerful, prescription-only medications. Buying them under the counter skips the medical checks that keep you safe. Obesity is a complex, long-term biological condition. Treating it successfully requires a lot more than just swallowing a tablet and hoping for the best. Medication is simply the tool that can help reduce hunger. The real work happens in the habits you build around it.
Our research showed that the public already understands this gap: only 27% of people believe that weight loss medication alone is enough to tackle obesity sustainably.1 On top of that, 26% of people say their biggest worry is simply putting all the weight back on the moment they stop taking the treatment.1
The numan take
Pills are a huge leap for accessibility. They’re also not a magic fix. If you take the medication alone and change nothing else, the weight usually returns. That's why safe, effective obesity care can't just be about handing out prescriptions. Lasting progress needs clinical monitoring, lifestyle changes, and regular coaching to protect your muscle and reset your relationship with food.
References
Numan / Attest Survey, May 2026. Data captured from a nationally representative sample of 2,000+ UK adults. Headline calculations based on a £35 cost per missed NHS appointment.
Joe is an avid writer. He loves puns and rhymes, but most importantly, strives to write copy that motivates men to change their lives for the better. Away from Numan, you can find Joe probably annoyed at a Watford F.C. game, enjoying a boogie at a disco night, or on a bike ride along the Thames.
Hassan is a specialist clinical pharmacist with a background in digital marketing and business development. He works as a Clinical Copywriter at Numan, leveraging his research and writing abilities to shine a light on the health complications affecting men and women.
